CII
CADX

CR Intrinsic Investors’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

CR Intrinsic Investors’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-764,922
Closed -$4.83M – 428
2013
Q3 		$4.83M Buy
+764,922
New +$4.83M 0.15% 183